{"nctId":"NCT02334813","briefTitle":"Daily Prednisone Versus Pulsed Dexamethasone in Treatment-na√Øve Adult Patients With Immune Thrombocytopenia","startDateStruct":{"date":"2002-07"},"conditions":["Purpura, Thrombocytopenic, Idiopathic"],"count":26,"armGroups":[{"label":"Arm A: daily prednisone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Prednisone"]},{"label":"Arm B: pulsed dexamethasone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Dexamethasone"]}],"interventions":[{"name":"Prednisone","otherNames":[]},{"name":"Dexamethasone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* First episode of ITP\n\nExclusion Criteria:\n\n* Pregnancy\n* Glucocorticoid intolerance","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Remission Duration","description":"Percentage of patients in ongoing remission at 6 months","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":9},"commonTop":["Petechiae","Hypokalemia","Hypertension","Hyperglycemia"]}}}